(Q71608778)

English

Increased systemic availability of loperamide after oral administration of loperamide and loperamide oxide with cotrimoxazole

scientific article published on 01 February 1996

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8838438

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8838438%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

title

Increased systemic availability of loperamide after oral administration of loperamide and loperamide oxide with cotrimoxazole (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8838438

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8838438%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

F Kamali

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8838438

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8838438%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

M L Huang

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8838438

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8838438%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

language of work or name

English

0 references

publication date

1 February 1996

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8838438

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8838438%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

published in

British Journal of Clinical Pharmacology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8838438

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8838438%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

volume

41

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8838438

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8838438%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8838438

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8838438%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

page(s)

125-128

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8838438

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8838438%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

Identifiers

DOI

10.1111/J.1365-2125.1996.TB00169.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8838438

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8838438%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

PubMed publication ID

8838438

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8838438

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8838438%20AND%20SRC:MED&resulttype=core&format=json

(Q71608778)

Increased systemic availability of loperamide after oral administration of loperamide and loperamide oxide with cotrimoxazole

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)